BIOLIGN CONFERENCE
The BIOLIGN Conference Guangzhou 2024 aims to provide a high-level platform for government agencies, local/multinational pharmaceutical companies, Biotech, CRO/CDMO/CMO, investment institutions, research institutes and universities, parks, intelligentization, automation, digitalization, detection/quality analysis, gene sequencing and multi-omics research, organoid/ animal models/drug sensitivity testing, instruments/equipment/reagents, cell culture/virus vectors/consumables, single-use technology, purification/separation, law firms/consulting firms and other relevant institutions to exchange ideas, refine consensus, gain insights into the frontier trends and technological innovations in the pharmaceutical industry, and jointly explore the path of collaborative innovation in the pharmaceutical biotechnology industry.
Click here for post-event highlights and live coverage of BIOLIGN Thousand-people Assembly in East China!
Download Post-event Report of East China ConferenceBIOLIGN 2024@Suzhou
2500+
ATTENDEES
150+
SPEAKERS
500+
B2B MATCHMAKING
80+
SPONSORS
New Quality Forces New Growth Unleashed
Part of Previous Speakers
Job Titles Align with the Newest Information